Intra-articular administration of autologous adipose-derived stem cells in hip osteoarthritis: Longitudinal treatment trajectories and prognostic factors

Intra-articular ASC treatment enhanced patient-reported outcomes over 6 months, with differences observed across hip OA severities. Female sex and moderate hip OA were positive prognostic factors, whereas ligamentum teres abnormalities were negative prognostic factors for patient-reported outcomes after ASC treatment. These findings can be used to inform patients and clinicians about the expected course of treatment and aid clinical decision-making regarding the use of intra-articular ASC treatment for hip OA.

Authors

Institutions

Publication Details

Journal
Regenerative Therapy
Published
2025-03-28
DOI
https://doi.org/10.1016/j.reth.2025.03.010
Citations
1
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
1.67
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intra-articular administration of autologous adipose-derived stem cells in hip osteoarthritis: Longitudinal treatment trajectories and prognostic factors

Shuichi Yoshida, Taku Saito, Ryota Yamagami, Tomohiro Terao et al.
1 citations
Regenerative Therapy
Osteoarthritis Treatment and Mechanisms
1.67
article

Intra-articular administration of autologous adipose-derived stem cells in hip osteoarthritis: Longitudinal treatment trajectories and prognostic factors

Shuichi Yoshida, Taku Saito, Ryota Yamagami, Tomohiro Terao, Hisatoshi Ishikura, Yuji Maenohara, Shinsaku Tsuji, Sakae Tanaka, Junya Higuchi, Masaki Hatano, Yusuke Arino, Taro Kasai, Yuma Makii, Tokio Matsuzaki, Ryo Murakami, Masashi Sato, Keita Inoue
article en
1 citations

Abstract

Intra-articular ASC treatment enhanced patient-reported outcomes over 6 months, with differences observed across hip OA severities. Female sex and moderate hip OA were positive prognostic factors, whereas ligamentum teres abnormalities were negative prognostic factors for patient-reported outcomes after ASC treatment. These findings can be used to inform patients and clinicians about the expected course of treatment and aid clinical decision-making regarding the use of intra-articular ASC treatment for hip OA.

Regenerative TherapyVol. 29
Ochanomizu University (JP), SMC Corporation (Japan) (JP), GC Corporation (Japan) (JP), Chiba Rosai Hospital (JP), The University of Tokyo (JP)
Good health and well-being
Openalex Percentile: Top 19%
Osteoarthritis Treatment and Mechanisms
1.67
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.